Viatris Inc (VTRS)
17.01
-0.58 (3.30%)
Upcoming Events
Latest Headlines
Increasing unusual put option volume: VTRS CARR ATAI BIRK AR MDY DHI HAS ZION CMPS
July 21, 2026 5:37 AM - StreetInsider
Form 4 Viatris Inc For: Jun 30 Filed by: SIMMONS DAVID S
July 1, 2026 6:02 PM - SEC Filing
Form 4 Viatris Inc For: Jun 30 Filed by: Groothuis Leo Frans
July 1, 2026 6:00 PM - SEC Filing
Viatris refinances ¥40 billion Japanese yen term loan facility
July 1, 2026 4:24 PM - StreetInsider
Form 8-K Viatris Inc For: Jul 01
July 1, 2026 4:21 PM - SEC Filing
Viatris to Report Second-Quarter 2026 Financial Results on August 6, 2026
July 1, 2026 6:59 AM - PR NewsWire
Viatris Phase 3 Japan trial of kidney drug VR-205 meets primary endpoint
June 29, 2026 6:59 AM - StreetInsider
Viatris Announces Positive Top-Line Results from Phase 3 Study of VR-205 in Japanese Adults with Primary Immunoglobulin A Nephropathy
June 29, 2026 6:59 AM - PR NewsWire
Form 4 Viatris Inc For: Jun 25 Filed by: Campbell Paul
June 26, 2026 5:00 PM - SEC Filing
Viatris (VTRS) PT Raised to $119 at Morgan Stanley
June 26, 2026 8:20 AM - StreetInsider
Form 144 Viatris Inc Filed by: Campbell Paul
June 25, 2026 4:28 PM - SEC Filing
Increasing unusual put option volume: VTRS ACI STRC PURR BSOL HTZ CDNS
June 22, 2026 5:55 AM - StreetInsider
Form 8-K Viatris Inc For: Jun 17
June 18, 2026 4:11 PM - SEC Filing
Form 8-K Viatris Inc For: Jun 12
June 15, 2026 4:32 PM - SEC Filing
Form FWP Viatris Inc Filed by: Viatris Inc
June 12, 2026 4:11 PM - SEC Filing
Viatris Inc (VTRS) 4200 contracts of July 15 puts trade
May 27, 2026 2:49 PM - StreetInsider
Viatris (VTRS) PT Raised to $22 at Barclays
May 19, 2026 3:58 AM - StreetInsider
FDA accepts Viatris drug application for fast-acting meloxicam pain treatment
May 18, 2026 8:02 AM - StreetInsider
U.S. FDA Accepts Viatris New Drug Application for Fast-Acting Meloxicam for the Treatment of Moderate-to-Severe Acute Pain
May 18, 2026 8:01 AM - PR NewsWire
Form 8-K Viatris Inc For: May 15
May 15, 2026 4:34 PM - SEC Filing
Viatris (VTRS) PT Raised to $20 at Truist Securities
May 7, 2026 5:04 PM - StreetInsider
Viatris to Present at the Bank of America Securities 2026 Healthcare Conference
May 7, 2026 4:30 PM - PR NewsWire
Form 10-Q Viatris Inc For: Mar 31
May 7, 2026 4:04 PM - SEC Filing
Form 8-K Viatris Inc For: May 07
May 7, 2026 7:48 AM - SEC Filing
Viatris Inc (VTRS) Tops Q1 EPS by 8c, provides guidance
May 7, 2026 7:01 AM - StreetInsider
Viatris Reports First-Quarter 2026 Financial Results
May 7, 2026 6:59 AM - PR NewsWire
FDA greenlights continued generic access for Micardis
May 6, 2026 8:58 AM - StreetInsider
Form SCHEDULE 13G/A Viatris Inc Filed by: DAVIS SELECTED ADVISERS
May 5, 2026 10:02 AM - SEC Filing
Viatris Announces Quarterly Dividend
May 5, 2026 6:59 AM - PR NewsWire
Viatris Inc (VTRS) Declares $0.12 Quarterly Dividend; 3.2% Yield
May 5, 2026 6:59 AM - StreetInsider
Form 8-K Viatris Inc For: May 01
May 4, 2026 4:39 PM - SEC Filing
Viatris names Paul Campbell interim CFO as Doretta Mistras departs
May 4, 2026 4:30 PM - StreetInsider
Viatris Announces Chief Financial Officer Transition
May 4, 2026 4:30 PM - PR NewsWire
Viatris to present contraceptive patch data at ACOG meeting
May 1, 2026 7:00 AM - StreetInsider
Viatris Announces Several Data Presentations on Investigational Low-Dose Estrogen Combined Hormonal Contraceptive Weekly Patch at the 2026 American College of Obstetricians and Gynecologists Annual Cl
May 1, 2026 6:59 AM - PR NewsWire
Form SCHEDULE 13G Viatris Inc Filed by: VANGUARD CAPITAL MANAGEMENT LLC
April 30, 2026 2:25 PM - SEC Filing
Full Article List
